Author

Omar El Ouarzadi

Observed name: O. El Ouarzadi

Institution: Université de Montréal

Observed institutions: Centre Hospitalier de l’Université de Montréal, Institut du cancer de Montréal, Université de Montréal

OpenAlex ID: A5000623609

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy

2023 · Francis Proulx-Rocray, Bertrand Routy, et al. · Cancer Treatment and Research Communications · 23

Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma

2023 · Cecilia Hes, Antoine Desilets, et al. · Oral Oncology · 21

679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors

2020 · Corentin Richard, Myriam Benlaifaoui, et al. · Regular and Young Investigator Award Abstracts · 15

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and the influence of the NLR in NSCLC patients treated with immunotherapy.

2021 · Francis Proulx-Rocray, Bertrand Routy, et al. · Journal of Clinical Oncology · 7

Efficacy of Advanced Therapies as Prophylaxis and for Active Disease in Postoperative Crohn’s Disease: A Comprehensive Review

2025 · Atena Karimi, Alessandro David, et al. · Journal of Clinical Medicine · 2

A fishy situation – expanding the differential diagnosis of the fish-mouth papilla

2026 · Omar El Ouarzadi, Reda Goudrar, et al. · Endoscopy

901P Gut microbiome metagenomics and toxicity outcomes from chemoradiation therapy in head and neck squamous cell carcinoma

2023 · A. Desilets, C. Hermosilla Samayoa, et al. · Annals of Oncology

Works count: 7

Citation count: 68

H-index: 4

I10-index: 3